Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ia Single-center,Randomized,Double-blind,Placebo-controled Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.

NCT04277897 is registered in ClinicalTrials.gov with Xi'an Xintong Pharmaceutical Research Co.,Ltd. as lead sponsor.

NCT NCT04277897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04277897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ia Single-center,Randomized,Double-blind,Placebo-controled Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.
Lead sponsor
Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
March 15, 2020
Completion date
September 30, 2020
Enrollment
69 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b